| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |